Electromed Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
17.2%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
$1.22next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q1 Fiscal 2027 Earnings Release | 11 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Direct Homecare Field Sales Representatives Quarterly57.0Target: Sustained expansion of direct sales force to drive prescription volumes
Annualized Homecare Revenue per Weighted Average Direct Sales Representative Quarterly1.2MTarget: 1000000 to 1100000
Gross Profit Margin Quarterly7,880.0%Target: Mid-to-high 70% range
Watch Items
- Sales Force Productivity and Headcount ExpansionTrigger: Average direct sales representative count falling below 50 or annualized productivity dropping below $1,000,000Action: Re-evaluate sales training, regional territory allocations, and recruitment pipelines.
- Gross Margin CompressionTrigger: Gross margin dropping below 75%Action: Review manufacturing optimization, component pricing, and average selling price (ASP) per SmartVest device.
- Reimbursement and Covered Lives ContractsTrigger: Loss of major commercial payer contracts or reduction in the 86% covered lives metricAction: Engage reimbursement specialists and policy teams to appeal payer decisions and demonstrate clinical efficacy of SmartVest.
Research as of 20 Jun 2026